Santa Cruz Biotechnology offers a broad range of Ly-49F monoclonal antibodies for immunology and cell biology research. Ly-49F monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ly-49F is a member of the Ly-49 family of receptors, which regulate natural killer (NK) cell activity. The Ly-49F receptor significantly influences immune response by recognizing specific ligands on target cells, impacting NK cell-mediated cytotoxicity and cytokine production. Understanding Ly-49F functionality provides valuable insights into immune regulation mechanisms. Research focusing on Ly-49F continues to reveal important aspects of NK cell biology and immune system function. Investigating Ly-49F aids in developing new approaches for cancer treatment and infectious disease management. Current studies highlight the importance of Ly-49F in maintaining immune system balance and homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and potential therapeutic applications.